Apollo Chennai Advances Cardiac Care with First Subcutaneous ICD Implant

Apollo Hospitals, Greams Road, Chennai continues to lead in clinical innovation and patient-focused cardiac care with the successful implantation of a Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) — a cutting-edge device that offers life-saving protection from sudden cardiac arrest without placing leads inside the heart. Performed by Dr. A. M. Karthigesan, Senior Consultant Cardiologist & Electrophysiologist, and his team, the procedure represents a significant advancement in rhythm-management therapy and underscores Apollo’s commitment to evidence-based, outcomes-driven care.
 

Unlike conventional ICDs that rely on transvenous leads placed within the heart, the subcutaneous ICD (S-ICD) delivers effective protection from life-threatening arrhythmias without entering the heart or blood vessels. Positioned entirely beneath the skin, it preserves cardiac and vascular anatomy, simplifies the implantation approach, and significantly reduces long-term complications associated with transvenous leads, including infection and lead failure. This strategy is aligned with global electrophysiology best practices, enhancing patient safety while ensuring reliable defibrillation therapy.
 

This advancement is part of Apollo Chennai’s broader leadership in cardiac care, which includes pioneering minimally invasive therapies, electrophysiology innovations, and comprehensive heart rhythm management. By integrating world-class technology with compassionate care, Apollo Hospitals reinforces its mission to improve cardiovascular outcomes and quality of life for patients at risk of sudden cardiac events.
 

Apollo’s S-ICD milestone exemplifies how evidence-based innovation can translate into safer, more effective care — strengthening confidence for patients and clinicians alike.